Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST

By afschroeder • July 2, 2026

Coates LC, Gladman DD, Merola JF, Mrowietz U, Armstrong A, Baraliakos X, Tillett W, Kishimoto M, Reddy J, Teng L, Amouzadeh H, Deignan C, Mease PJ, Gossec L. Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST. Rheumatology (Oxford). 2026 Jul 1:keag351. doi: 10.1093/rheumatology/keag351. Epub ahead of print. PMID: 42384964.

Tags: apremilast, Dermatology, Disease activity, disease progression, oligoarticular, polyarticular, PsA, psoriatic arthritis, Publications

GRAPPA 2025 Annual Meeting Report: Session on Geographic Variations in Psoriatic Arthritis/Psoriasis Care and Resource Limitations

Ma EJ, Boit R, Leung YY, Singla S, Fernández-Ávila D, Kalyoncu U, Armstrong AW. GRAPPA 2025 Annual Meeting Report: Session on Geographic Variations in Psoriatic[...]

Paradoxical melanoma in situ arising in a depigmented patch secondary to immunotherapy

Shah KS, Kang Y, Opene C. Paradoxical melanoma in situ arising in a depigmented patch secondary to immunotherapy. JAAD Case Rep. 2026 May 15;74:115-117. doi:[...]

Occupational epidemiology of acral lentiginous melanoma

Guo L, Kikuchi R, Armstrong AW, Chen SC. Occupational epidemiology of acral lentiginous melanoma. JID Innov. 2026 Apr 1;6(4):100473. doi: 10.1016/j.xjidi.2026.100473. PMID: 42383094; PMCID: PMC13316556.